We believe in ensuring healthy lives and wellbeing for all. By forming strategic partnerships with our customers, we speed up and streamline product development processes and drive innovation.
While many of the challenges in the Life Sciences industry are well known the great diversity and the pace of change in the sector is a challenge in itself. We at TECHNIA have a proven record of supporting renowned companies within the Life Science industry by streamlining processes, reducing time to market and increasing profitability while maintaining quality and meeting regulatory demands.
To improve the patient experience, companies must take on a holistic approach to product development. By including patient-specific aspects such as genome, behavior and environment in the innovation processes a higher level of product personalization can be achieved.
Achieving regulatory compliance while increasing profitability and competitiveness is a genuine challenge to the Life Sciences industry. By embedding quality into every stage of the product lifecycle it is easy to have full control of all the details that pertain to products, parts, reagents, manufacturing, and compliance.
As organizations grow and new departments are formed, essential data often becomes isolated within departments. This can inhibit innovation and increase the risk of error. By connecting systems, people, and data in an integrated, virtual ecosystem your innovators are given the information they need to make the best decisions at the right time.
A predictive and adaptive manufacturing approach to development and manufacturing results in high quality, personalized products. PLM is not only a software but a way of re-evaluating old habits and transforming your way of working.
Leaders of tomorrow need to understand patient desire and market demand to adopt new business models with distributed and adaptive supply chains. They will execute the value chain as one integrated whole, including collaboration and integration with patients, physicians, suppliers, and partners.
The essence of PLM is to create automated and seamlessly integrated, fully traceable processes across the entire product lifecycle. When implemented correctly, the outcome is reduction of risk and cost and full enablement of the innovation potential within your company. It’s a competitive advantage that few companies can afford to overlook.
Combining the key applications from the Dassault Systèmes software brands, the 3DEXPERIENCE platform is a simple, unified PLM environment. The architecture means that product data can be transferred seamlessly between all applications, providing the user with a single, easy-to-use interface.
BIOVIA solutions, from Dassault Systèmes, create an unmatched scientific management environment that can help science-driven companies create and connect biological, chemical, and material innovations to improve the way we live.
TECHNIA.Cloud, built on Dassault Systèmes’ PLM platform 3DEXPERIENCE, brings you cloud capability and deep PLM expertise customised to your business needs. Learn about the benefits and costs associated with Cloud PLM vs traditional on-premise PLM deployments and find out if you should consider a migration to the Cloud.
TECHNIA have more than 30 years of experience of implementing, customizing, and maintaining PLM solutions. While our domain expertise span trough development, system architecture, engineering and research, many of us have a background in the Life Sciences industry. The services we provide cover all the aspects of your PLM implementation from pre studies, proof of concept and value models to process optimization, integrations, support, and training.
From concept to design, development and manufacturing. Turning more innovations into successful medical devices. PLM is a proven solution in the Medical Device industry. It allows your business to reduce time-to-market by making the product development process much more efficient, whilst at the same time ensuring regulatory compliance.
From discovery to development and manufacturing. Making the delivery of new treatments and diagnostic procedures faster and more reliable. Pharmaceuticals and Biotech companies must reduce time to market, streamline processes, increase revenues and cut costs while meeting stringent regulatory requirements.